Largest disclosed lower bound
Gilbert Ray Cisneros, Jr. · $1.0K–$15.0K
Purchase · traded 2026-08-20 → filed 2026-09-10. Ranked over every AGIO row by the provable lower bound, never a point estimate.
Public record / Tickers / AGIO
AGIO — AGIOS PHARMACEUTICALS, INC.†
Both disclosure regimes on one name: who in Congress filed about AGIO, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
- Congress txns
- 8 all PTR rows naming AGIO
- Members · 12m
- 1 3 buys · 0 sells · by trade date
- Latest PTR
- 09-10 filed 2026-09-10
- 13F holders
- — ticker not resolved to an issuer
Congress = transactions in statutory ranges, 45-day lag · Institutions = quarter-end positions, 45-day lagas of 2026-09-14 13:21 UTCno price data — a disclosure record, not a chart
Congress · trailing 12 months
1 member · 3 buys / 0 sells
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Timeliness
Every row filed inside the 45-day window
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
Congress · disclosure timeline
TRADE DATES · 24M · ▲ BUY ▼ SELL · HEIGHT = LOG LOWER BOUND5 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds.
Trade date, not filing date — the lag lives in the table below. 5 rows placed.
PLANNED institutional holder flow by quarter
Congressional disclosures
ALL PTR ROWS NAMING AGIO · SORTED FILED ↓ · STATUTORY RANGES · FILED ≤45D LATEfull congressional view ↗| Filed ▾ | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2026-09-10 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 08-20 +21d | $1K–$15K | ||
| 2026-04-07 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 03-03 +35d | $1K–$15K | ||
| 2026-01-12 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 2025-12-11 +32d | $1K–$15K | ||
| 2025-05-06 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 04-17 +19d | $1K–$15K | ||
| 2025-02-11 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 01-29 +13d | $1K–$15K |
Traded → filed dates on every rowEach row shows the trade date and the filing date; the gap between them is the disclosure lag.all 8 ↗
Members active in AGIO
12M · NET LOWER BOUND · COMMITTEES AS OF TRADE DATE · SNAPSHOT 2026-09-14| Member | Rows | NetNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point. | CommitteesNumber of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join. |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D–CA-31 | 3 | $3.0K to $45.0K | 2 |
1 members in the window · counts of disclosures, not dollars.
Congress ↔ notable managers · AGIO
who in Congress disclosed purchases or sales beside which notable managers added or trimmedCongress · last 90 days
- Buyers
- 1 Gilbert Ray Cisneros, Jr. D–CA-31 $1K–$15K
- Sellers
- 0 — —
filed 2026-06-16 → 2026-09-14 · totals are statutory ranges
Notable managers PLANNED
Ticker not yet mapped — the 13F side needs a reviewed name-and-class mapping row for AGIO. how tickers are mapped ↗
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-09-10 | Gilbert Ray Cisneros, Jr. Congress | Purchase | $1K–$15K |
1 newest rows · Congress rows date by filing, 13F rows by quarter end · a 13F row is a quarter-end snapshot, not a trade
Institutional holders · 13F
Mapped, but not in the published aggregate.
AGIO resolves to AGIOS PHARMACEUTICALS, INC. (CIK 0001439222), but this build's aggregate holds no entity-keyed top-holder rows for it. AGIO on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to AGIOS PHARMACEUTICALS, INC. (CIK 0001439222), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Do the two regimes agree?
TRAILING 12M · CONGRESS vs FILERS NETCongress net (rows)3 buy / 0 sell
Congress net ($ bound)$3.0K to $45.0K
Filers net (actions)not in build
Filers net ($ Q/Q)not in build
The ticker resolves to AGIOS PHARMACEUTICALS, INC. (CIK 0001439222), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so the filer side cannot be computed. Convergence and divergence are stated only when both sides are computed.
Signals on AGIO
RETAINED WINDOW · ACTIVE HITS| Kind | Rule | Hits |
|---|---|---|
| COMMITTEE | a disclosed trade in an issuer whose sector falls within a committee the member sat on as of the trade date (versioned mapping; membership dated) — context only: no legal, ethical, or causal conflict is established or implied | 1 hit |
Planned modules for AGIO · financials and macro
Financials — as filed PLANNED
AGIO's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: AGIO on EDGAR ↗
Macro context PLANNED
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.
† issuer name from the SEC's present-day ticker file (company_tickers.json) — a present-day mapping, not the name as of each filing